Anti-EBNA-1 IgG is not a reliable marker of multiple sclerosis clinical disease activity.
Ingram, G.; Bugert, J. J.; Loveless, S.; Robertson, N. P.; European Journal of Neurology, 2010, vol. 17, issue 11, p 1386, ISSN 13515101. ISBN 14681331.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef